China Allergy Diagnostics Market (2026-2031)
The China Allergy Diagnostics Market was valued at $320.2 Million in 2026 and projected to reach to $567.5 Million by 2031, representing a compound annual growth rate of 12.1%. China's allergy diagnostics market is positioned for sustained growth through 2031, driven by rising allergic disease prevalence linked to urbanization and environmental factors.
China Allergy Diagnostics Market Trends and Insights
- This growth trajectory reflects China's rising prevalence of allergic diseases, increasing healthcare spending, and expanding diagnostic infrastructure across urban and emerging markets.
- China's market is outpacing global averages, driven by growing awareness of allergy testing and improved access to advanced diagnostic technologies. The allergy diagnostics sector in China benefits from rapid urbanization, environmental factors, and a growing middle-class population seeking preventive healthcare solutions.
- China's healthcare reforms and investment in diagnostic capabilities are accelerating adoption of immunoassay and molecular testing platforms.
- Between 2026 and 2031, China is expected to consolidate its position as a key growth engine within the Asia Pacific region, with expanding clinical laboratory networks and rising demand for personalized allergy management..
Key Market Statistics
- CAGR (2026-2031) 12.1% CAGR
- Market Size, 2026 ~USD 320.2 Million
- Forecast, 2031 ~USD 567.5 Million
- Country China
China Allergy Diagnostics Market Overview
Rapid Market Expansion :
China's allergy diagnostics market is growing at 12.1% CAGR, significantly outpacing the global rate of 9.6%, driven by increasing allergy prevalence and healthcare modernization across urban centers.
Rising Allergy Prevalence :
Growing environmental pollution, changing lifestyles, and increased awareness of allergic diseases in China are driving higher diagnostic demand among both urban and emerging market populations.
Healthcare Infrastructure Investment :
Expanding diagnostic capabilities and increased healthcare spending in China are enabling broader access to allergy testing services, particularly in tier-2 and tier-3 cities.
Market Valuation Growth :
The market is valued at USD 320.2 million in 2026 and projected to reach USD 567.5 million by 2031, representing a 77% increase over the five-year forecast period.
China Allergy Diagnostics Market Dynamics
- Increased healthcare spending and government initiatives to improve diagnostic infrastructure are expanding market accessibility beyond major cities into secondary and tertiary markets.
- The market's 12.1% CAGR reflects strong demand for both traditional and advanced diagnostic solutions. Key growth catalysts include growing patient awareness, integration of digital health platforms, and expansion of diagnostic laboratories.
- As China's middle class expands and healthcare quality expectations rise, investment in allergy diagnostics will accelerate.
- Strategic partnerships between domestic and international diagnostic providers will further enhance market penetration and innovation in testing methodologies..
Related Ecosystem
In Vitro Diagnostics
- Polymerase Chain Reaction (PCR)
- Enzyme-Linked Immunosorbent Assay (ELISA)
- Dna Microarrays
- Assay Kits
- Microarrays
- ROCHE HOLDINGS AG
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Abbott Laboratories
- Biomerieux s.a.
Key Takeaways
- China's allergy diagnostics market is valued at USD 320.2 million in 2026 and will grow to USD 567.5 million by 2031, representing a 12.1% CAGR.
- China's market growth significantly outpaces the global average of 9.6% CAGR, positioning the country as a high-growth priority market.
- Rising allergic disease prevalence, urbanization, and healthcare modernization are primary drivers of China's diagnostic market expansion.
- China's expanding laboratory infrastructure and increasing adoption of advanced immunoassay technologies are reshaping the competitive landscape.
Allergy Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | IN VITRO TESTS (Test Type) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 9.6% from 2026 to 2031 |
| Largest Segment | CONSUMABLES (Product & Service) |
| Market Size Base Year (Billions) | ~USD 6.81 (2026) |
| Revenue Forecast (Billions) | ~USD 10.77 (2031) |
| Segments Covered | Product & Service, Type, Test Type, Allergen, End User |
China Allergy Diagnostics Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product & Service
- Consumables
- Instruments
- Services
By Type
- Immunoassay Analyzers
- Luminometers
- Other In Vivo Tests
- Other Instruments
- Patch Tests
- Skin Prick Tests
By Test Type
- In Vitro Tests
- In Vivo Tests
By Allergen
- Drug Allergens
- Food Allergens
- Inhaled Allergens
- Other Allergens
By End User
- Academic Research Institutes
- Diagnostic Laboratories
- Hospital-Based Laboratories
- Other End Users
Target Audience
- Diagnostic Device Manufacturers : Need China-specific market data to develop localized product strategies, identify distribution opportunities, and understand competitive positioning in this high-growth diagnostic market.
- Healthcare Investment Firms : Require detailed market valuation, growth projections, and trend analysis to evaluate investment opportunities in China's expanding allergy diagnostics sector and identify portfolio companies.
- Hospital & Laboratory Networks : Need insights into market demand, diagnostic infrastructure gaps, and regional growth patterns to plan service expansion and procurement strategies across China's diverse markets.
- Pharmaceutical & Biotech Companies : Require understanding of allergy prevalence trends, diagnostic adoption rates, and market dynamics to develop complementary therapeutics and companion diagnostic strategies in China.
- Market Entry & Expansion Consultants : Need comprehensive China market intelligence, competitive landscape analysis, and growth drivers to advise clients on market entry strategies and business development opportunities.
Key Companies in the China Allergy Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| TECAN GROUP LTD. | Switzerland |
TECAN GROUP LTD.
TECAN GROUP LTD. is a Swiss life sciences company providing laboratory automation and diagnostic instruments.
Reasons to Buy this Report
- Market Size & Growth Validation : Obtain precise valuation data for China's allergy diagnostics market (USD 320.2M in 2026) with verified 12.1% CAGR projections through 2031, enabling accurate business planning and investment decisions.
- Competitive Positioning Intelligence : Understand China-specific market dynamics, regional variations between urban and emerging markets, and competitive landscape to identify opportunities for market entry or expansion strategies.
- Demand Forecasting & Trend Analysis : Access detailed insights into China's rising allergy prevalence, healthcare spending patterns, and diagnostic infrastructure development to forecast demand and align product portfolios accordingly.
- Strategic Investment Guidance : Leverage comprehensive market data to evaluate investment opportunities in China's high-growth allergy diagnostics sector, with clear growth trajectories and market drivers identified.
- Regulatory & Market Access Insights : Gain understanding of China's healthcare infrastructure expansion, diagnostic market accessibility across tiers, and growth catalysts essential for successful market penetration strategies.
Frequently asked questions
What is the current size of China's allergy diagnostics market?
China's allergy diagnostics market is valued at USD 320.2 million in 2026 and is projected to reach USD 567.5 million by 2031.
What is the expected growth rate for China's allergy diagnostics market?
China's allergy diagnostics market is expected to grow at a compound annual growth rate (CAGR) of 12.1% from 2026 to 2031.
How does China's market growth compare to global trends?
China's 12.1% CAGR significantly exceeds the global average of 9.6%, making China one of the fastest-growing markets for allergy diagnostics.
What factors are driving growth in China's allergy diagnostics market?
Key drivers include rising allergic disease prevalence, rapid urbanization, healthcare system modernization, increased healthcare spending, and growing consumer awareness of allergy testing.
Which diagnostic technologies are gaining traction in China?
China is seeing increased adoption of immunoassay platforms, molecular testing technologies, and component-resolved diagnostics as clinical laboratories expand their capabilities.
RESEARCH METHODOLOGY
The study involved major activities in estimating the current market size for the global Allergy Diagnostic market. Exhaustive secondary research was done to collect information on the allergy diagnostic market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, such as top-down and bottom-up, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market sizes of the allergy diagnostic market's segments and subsegments.
Secondary Research
This research study involved the wide use of secondary sources, directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, Factiva, whitepapers, and companies’ in-house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the allergy diagnostic market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other market-related personnel from various companies and organizations operating in the allergy diagnostic market. Primary sources from the demand side included vice presidents in hospitals & clinics, C-level executives, department heads, doctors/physicians, hospital supply management teams, clinic personnel, and laboratory technicians.
Breakdown of Primary Interviews
Note 1: C-level primaries include CEOs, COOs, and CTOs.
Note 2: Others include sales managers, marketing managers, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = <USD 500 million
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the allergy diagnostic market. These methods were also widely used to estimate the sizes of various subsegments in the market. The research methodology used to estimate the market size includes the following:
Data Triangulation
The market was divided into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the market engineering process and arrive at precise statistics for all segments.
Approach to derive the market size and estimate market growth: Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of allergy diagnostic products. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.
Market Definition
Allergy testing helps determine the substances causing a patient's allergy symptoms. Tests include skin tests, intradermal tests, challenge tests, blood tests, and patch tests. Allergists commonly conduct challenge tests, including food, inhalation, drug, and physical challenges. Blood tests are generally used when unsafe or unapplicable skin tests are required, such as when consuming certain medications or having a skin condition that may interfere with skin testing. Allergy tests, such as in vitro & in vivo tests, are performed to determine the cause, stage, prognosis, and treatment course for allergic diseases.
Key Stakeholders
- Allergy Diagnostic Reagents, Kits, and Instrument Manufacturers
- Allergy Diagnostic Vendors and Distributors
- Hospitals
- Diagnostic Laboratories
- Allergy Diagnostic Service Providers
- Academic Research Institutes
- Venture Capitalists and Investors
- Contract Research Organizations (CROs)
Report Objectives
- To describe, analyze, and forecast the allergy diagnostic market, by product & service, test type, allergen, end user, and region
- To describe and forecast the allergy diagnostic market for key regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC countries
- To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the allergy diagnostic market
- To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s Five Forces, and prices pertaining to the market under study
- To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To profile key players and comprehensively analyze their market shares and core competencies in the allergy diagnostic market
- To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the allergy diagnostic market
Available customizations:
With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to 5)
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company
Geographic Analysis
- Further breakdown of the Rest of Asia Pacific allergy diagnostic market into Vietnam, New Zealand, and others
- Further breakdown of the Rest of Latin America allergy diagnostic market into Colombia, Chile, Ecuador, and others
- Further breakdown of the Rest of Europe allergy diagnostic market into Belgium, Russia, the Netherlands, Switzerland, and others
Get the Full Allergy Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Allergy Diagnostics Market.
- Canada Allergy Diagnostics Market
- US Allergy Diagnostics Market
- Germany Allergy Diagnostics Market
- UK Allergy Diagnostics Market
- France Allergy Diagnostics Market
- Italy Allergy Diagnostics Market
- Spain Allergy Diagnostics Market
- Japan Allergy Diagnostics Market
- India Allergy Diagnostics Market
- South Korea Allergy Diagnostics Market
- Australia Allergy Diagnostics Market
- Brazil Allergy Diagnostics Market
- Mexico Allergy Diagnostics Market
- GCC Countries Allergy Diagnostics Market
- Rest Of Europe Allergy Diagnostics Market
- Rest Of Asia Pacific Allergy Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report